The Latest
The WasteWatcherFTC Chair Khan Should Focus on Production and Prices Instead of Political Pressure
Mergers should be reviewed based on their benefits to consumers, not pressure from members of Congress.
State ActionCCAGW Urges Governor Reeves to Veto House Bill 728
HB 728 would change how the federal 340B program operates in Mississippi.
The WasteWatcherThe FCC's Not So Merry-Go-Round of Net Neutrality
The Biden administration’s creates uncertainty for future of broadband deployments across America and wastes taxpayer resources.
Op-EdsA ‘D’ for the USPS Delivering for America plan
The USPS delivers at least one thing consistently. It has lost money in every quarter since 2007.
The WasteWatcherPresident Biden's Budget Will Raise Taxes and Federal Debt
President Biden's FY 2025 budget would increase government spending, restore IRS funding, and raise taxes
The 340B Drug Pricing Program Needs a New Prescription
Federal healthcare programs are often well-intended but end up costing more than expected and become subject to waste, fraud, abuse, and mismanagement.
The WasteWatcherRate Setting for BEAD Funds Is Forcing States to Consider the Impact of Inflation
NTIA's pressure to include unrealistic price caps without inflation adjustment may discourage provider participation.
State ActionCCAGW Urges Kentucky Representatives to Oppose SB 188
SB 188 would create unnecessary regulatory barriers that will undermine the effectiveness of pharmaceutical benefit managers (PBMs) in Kentucky.
The WasteWatcherMedicare Advantage Should Not Be Disadvantaged
Taxpayers and beneficiaries should be concerned with the Biden administration’s proposed cuts to Medicare Advantage.
Agency CommentsCAGW Files Comments with FCC on RDOF Emergency Petition
CAGW responds to an emergency petition filed by RDOF award winners asking for relief from the FCC's buildout requirements.
State ActionCCAGW Urges Governor Youngkin to Veto Senate Bill 274
SB 274 would impose price controls on prescription drugs. Price controls distort markets, hurt innovation, and exacerbate the problems they are created to fix.
State ActionCCAGW Urges Illinois Legislators to Oppose House Bill 4548
HB 4548 would create unnecessary regulatory barriers that will undermine the effectiveness of pharmaceutical benefit managers (PBMs) in Illinois.
